Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-134098

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 25, 2016
Accepted (ET)
Jul 27, 2016 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF2Jul 25, 2016S627$41.85D112,167D
Common stockF2,F3Jul 25, 2016S625$41.85D112,193ISee footnote
Common stockF4Jul 26, 2016S627$43.74D111,540D
Common stockF4,F3Jul 26, 2016S625$43.74D111,568ISee footnote
Common stockF5holding———12,500ISee footnote
Common stockF6holding———12,500ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses